Gene · 1048
Papers3,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research. | Int J Mol Sci | 2024 | 38256166 | PubTator, text mining | PubMed |
| Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer. | Cancers (Basel) | 2024 | 38254876 | PubTator, text mining | PubMed |
| Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting. | Cancers (Basel) | 2024 | 38254772 | PubTator, text mining | PubMed |
| Circulating Tumour Cells in the Prediction of Bone Metastasis. | Cancers (Basel) | 2024 | 38254743 | PubTator, text mining | PubMed |
| Solid basal adenoid cystic carcinoma of the breast: A case report and literature review. | Medicine (Baltimore) | 2024 | 38241532 | PubTator, text mining | PubMed |
| The emerging roles of CEACAM6 in human cancer (Review). | Int J Oncol | 2024 | 38240103 | PubTator, text mining | PubMed |
| Primary gastric squamous cell carcinoma: case report. | J Surg Case Rep | 2024 | 38239378 | PubTator, text mining | PubMed |
| CEACAM5 and TROP2 define metaplastic and dysplastic transitions in human antral gastric precancerous lesions and tumors. | Gastric Cancer | 2024 | 38221567 | PubTator, text mining | PubMed |
| Immune landscape and heterogeneity of cervical squamous cell carcinoma and adenocarcinoma. | Aging (Albany NY) | 2024 | 38206304 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence. | Cells | 2024 | 38201305 | PubTator, text mining | PubMed |
| Prognostic and predictive biomarkers in non-small cell lung carcinoma. | Pathology | 2024 | 38199926 | PubTator, text mining | PubMed |
| Carrier systems of radiopharmaceuticals and the application in cancer therapy. | Cell Death Discov | 2024 | 38195680 | PubTator, text mining | PubMed |
| Evolution of cell therapy for renal cell carcinoma. | Mol Cancer | 2024 | 38195534 | PubTator, text mining | PubMed |
| Antibodies to watch in 2024. | MAbs | 2024 | 38178784 | PubTator, text mining | PubMed |
| CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells. | Curr Cancer Drug Targets | 2024 | 38178674 | PubTator, text mining | PubMed |
| Integrated whole transcriptome profiling revealed a convoluted circular RNA-based competing endogenous RNAs regulatory network in colorectal cancer. | Sci Rep | 2024 | 38167453 | PubTator, text mining | PubMed |
| The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. | Cancer Commun (Lond) | 2024 | 38160327 | PubTator, text mining | PubMed |
| Toll-like receptor agonists as cancer vaccine adjuvants. | Hum Vaccin Immunother | 2024 | 38155525 | PubTator, text mining | PubMed |
| Tumor diagnosis using carbon-based quantum dots: Detection based on the hallmarks of cancer. | Bioact Mater | 2024 | 38034499 | PubTator, text mining | PubMed |
| A novel human single-domain antibody-drug conjugate targeting CEACAM5 exhibits potent in vitro and in vivo antitumor activity. | Acta Pharmacol Sin | 2024 | 38030799 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1048/papers?page=13